ASHLEY POURCIAU: Open Payments
NPI 1265873939 · NEW ROADS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 69 payments from 17 companies in 2025. Trend: 2023 $945 · 2024 $925 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $221 |
| Lilly USA, LLC | 12 | $169 |
| Novo Nordisk Inc | 10 | $158 |
| PFIZER INC. | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 3 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Corium, LLC | 3 | $38 |
Products named: VRAYLAR, JARDIANCE, Rybelsus, FANAPT, ELIQUIS, Ozempic, CAPLYTA, Jornay PM.
Industry payments across LA — which companies pay providers there.
